M. Schlumberger, R. Elisei, S. Müller et al.: Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma. In: Ann Oncol. Band28, Nr.11, 1. November 2017, S.2813–2819, doi:10.1093/annonc/mdx479, PMID 29045520, PMC 5834040 (freier Volltext).
M. Schlumberger, R. Elisei, S. Müller et al.: Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma. In: Ann Oncol. Band28, Nr.11, 1. November 2017, S.2813–2819, doi:10.1093/annonc/mdx479, PMID 29045520, PMC 5834040 (freier Volltext).